Net Medical Xpress Solutions, Inc. appointed Clara Jee, an experienced clinical trial nurse practitioner, to Head Variant Detection Programs that will be required for all clinical trial candidates.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.019 USD | +90.00% | +90.00% | +137.50% |
2022 | Net Medical Xpress Solutions, Inc. Appoints Clara Jee as Head of Variant Detection Program | CI |
2017 | Net Medical Xpress Solutions, Inc. Auditor Raises 'Going Concern' Doubt | CI |
1st Jan change | Capi. | |
---|---|---|
+137.50% | 716K | |
+10.02% | 3,082B | |
+8.25% | 84.92B | |
+4.44% | 78.23B | |
-14.19% | 54.06B | |
-23.14% | 46.79B | |
+21.96% | 45.87B | |
+21.64% | 42.68B | |
+59.16% | 37.28B | |
-10.56% | 24.89B |
- Stock Market
- Equities
- NMXS Stock
- News Net Medical Xpress Solutions, Inc.
- Net Medical Xpress Solutions, Inc. Appoints Clara Jee as Head of Variant Detection Program